July 9, 2024

Global Nuclear Medicine or Radiopharmaceuticals Market Analysis, Key Trends, Growth Opportunities, Challenges And Key Players By 2030

Nuclear Medicine or Radiopharmaceuticals Market

Nuclear Medicine or Radiopharmaceuticals Market was valued at USD 5700 million in 2021 and is expected to reach USD 9520 million by the year 2028, at a CAGR of 7.6%. Analysis period {2023-2030}

Nuclear medicine is the usage of radioactive substances in diagnostic or therapeutic procedures, particularly to treat various forms of cancer. Nuclear medicine employed in diagnosing or imaging process utilizes small amounts of radioactive substances called radiotracers. These radiotracers are generally injected into the bloodstream, inhaled, or swallowed by the patient where they localize to specific organs and emit radiation. The radiotracer moves through the area that is to be examined and radiates energy in the form of gamma rays. These gamma rays are detected by a special camera and a computer that generates images of the inner side of the body. Nuclear medicine imaging provides detailed unique information that is difficult to obtain using other imaging methods and it also has the potential to identify disease in its earliest stages. Moreover, radiopharmaceuticals are also administered as medicinal solutions containing radioisotopes. These radioactive medicines can destroy cancerous cells by emitting radiation when they reach the target cell.

Get Sample Report:-


Key Prominent Players In The Nuclear Medicine or Radiopharmaceuticals Market:

Actinium Pharmaceuticals Inc. (US) , Alliance Medical (UK), Avid Bioservices Inc (US), Bayer HealthCare Pharmaceuticals (Germany), Bracco Diagnostics Inc. (Italy), Cardinal Health Inc. (US), GE Healthcare (US), Ion Beam Applications S.A (Belgium), Jubilant Pharma (India), Lantheus Medical Imaging Inc. (US), Medi-Radiopharma Ltd (Hungary), Nordion Inc. (Canada), Novartis/Advanced Accelerator Applications (France), Positron Corporation (US) , Radiopharm Theranostics Ltd. (US), and other major players.

The latest report on the Nuclear Medicine or Radiopharmaceuticals market provides a detailed analysis of the market for the years 2023 to 2030. It presents a comprehensive overview of the global Nuclear Medicine or Radiopharmaceuticals industry, incorporating all key industry trends, market dynamics, competitive landscape, and market analysis tools such as Porter’s five forces analysis, Industry Value chain analysis, and PESTEL analysis of the Nuclear Medicine or Radiopharmaceuticals market. Moreover, the research covers crucial chapters such as Patent Analysis, Regulatory Framework, Technology Roadmap, BCG Matrix, Heat Map Analysis, Price Trend Analysis, and Investment Analysis which help to grasp the market direction and development in the present and forthcoming years. The report is meant to assist clients to obtain information and making decisions that will help them build their businesses. The study is produced with a specific aim in mind: to deliver business insights and consultation to help customers make wise business decisions and achieve long-term success in their particular market segments.

Read More: https://introspectivemarketresearch.com/reports/nuclear-medicine-or-radiopharmaceuticals-market/

The Report Will Include A Major Chapter

  • Patent Analysis
  • Regulatory Framework
  • Technology Roadmap
  • BCG Matrix
  • Heat Map Analysis
  • Price Trend Analysis
  • Investment Analysis
  • Company Profiling and Competitive Positioning
  • Industry Value Chain Analysis
  • Market Dynamics and Factors
  • Porter’s Five Forces Analysis
  • Pestle Analysis
  • SWOT Analysis

Segmentation of The Nuclear Medicine or Radiopharmaceuticals Market

This report has explored the key segments: by Type, By Modality, By Application, By End User and by Region. The lucrativeness and growth potential have been looked into by the industry experts in this report.

By Type         

  • Diagnostic
  • Therapeutic
  • Research

By Modality  

  • Single-Photon Emission Computed Tomography (SPECT) Radioisotopes
  • Positron Emission Tomography (PET) Radioisotopes
  • Beta Emitters
  • Alpha Emitters
  • Others

By Application          

  • Oncology
  • Thyroid
  • Cardiology
  • Neurology
  • Others

By End User  

  • Hospitals and Diagnostic Centers
  • Research Institutes

 By Region     

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, U.K., France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Bahrain, Kuwait, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Regional analysis includes country-level and regional market information, illustrating the market’s dynamics by the major segments included in the research. The research looks at both new technologies and current innovations that are expected to propel the industry forward in the next years.

Have a query? Market an enquiry before purchase@:


Overview of the market:

The report presents the overview of the market with the production of the cost, dispatch, application, use volume and arrangement. The Nuclear Medicine or Radiopharmaceuticals research report offers significant bits of information into the business focus from the early stage including some steady techniques chalked out by perceptible market pioneers to develop a strong foothold and development in the business. Moreover, the important areas of the Nuclear Medicine or Radiopharmaceuticals market are also assessed on the basis of their performance.

Report includes Competitor’s Landscape:

➊ Major trends and growth projections by region and country

➋ Key winning strategies followed by the competitors

➌ Who are the key competitors in this industry?

➍ What shall be the potential of this industry over the forecast tenure?

➎ What are the factors propelling the demand for the Nuclear Medicine or Radiopharmaceuticals?

➏ What are the opportunities that shall aid in significant proliferation of the market growth?

➐ What are the regional and country wise regulations that shall either hamper or boost the demand for Nuclear Medicine or Radiopharmaceuticals?

➑ How has the covid-19 impacted the growth of the market?

➒ Has the supply chain disruption caused changes in the entire value chain?

Table of Content:

Chapter 1: Introduction

1.1 Research Objectives

1.2 Research Methodology

1.3 Research Process

1.4 Scope and Coverage

1.4.1 Market Definition

1.4.2 Key Questions Answered

1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment

3.1 By Type

3.2 By Modality

3.3 By Application

3.4 By End User

Chapter 4: Market Landscape

4.1 Porter’s Five Forces Analysis

4.1.1 Bargaining Power of Supplier

4.1.2 Threat of New Entrants

4.1.3 Threat of Substitutes

4.1.4 Competitive Rivalry

4.1.5 Bargaining Power Among Buyers

4.2 Industry Value Chain Analysis

4.3 Market Dynamics

4.3.1 Drivers

4.3.2 Restraints

4.3.3 Opportunities

4.5.4 Challenges

4.4 Pestle Analysis

4.5 Technological Roadmap

4.6 Regulatory Landscape

4.7 SWOT Analysis

4.8 Price Trend Analysis

4.9 Patent Analysis

4.10 Analysis of the Impact of Covid-19

4.10.1 Impact on the Overall Market

4.10.2 Impact on the Supply Chain

4.10.3 Impact on the Key Manufacturers

4.10.4 Impact on the Pricing

Chapter 5: Nuclear Medicine or Radiopharmaceuticals Market by Type

5.1 Nuclear Medicine or Radiopharmaceuticals Market Overview Snapshot and Growth Engine

5.2 Nuclear Medicine or Radiopharmaceuticals Market Overview

5.3 Diagnostic

5.3.1 Introduction and Market Overview

5.3.2 Historic and Forecasted Market Size (2016-2028F)

5.3.3 Key Market Trends, Growth Factors and Opportunities

5.3.4 Diagnostic: Geographic Segmentation


Obtain this report:


Study These Reports Published By Introspective Market Research:




About Us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyse extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1 773 382 1049

Email: sales@introspectivemarketresearch.com

LinkedIn | Twitter | Facebook

Leave a Reply

Your email address will not be published. Required fields are marked *